These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19665133)

  • 1. Measuring tendon properties in mdx mice: cell viability and viscoelastic characteristics.
    Rizzuto E; Musarò A; Catizone A; Del Prete Z
    J Biomech; 2009 Oct; 42(14):2243-8. PubMed ID: 19665133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophic tendon functionality is recovered by muscle-specific expression of insulin-like growth factor in mdx mice.
    Rizzuto E; Catizone A; Musarò A; Del Prete Z
    J Biomech; 2013 Feb; 46(3):604-7. PubMed ID: 23122221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice.
    Hakim CH; Grange RW; Duan D
    J Appl Physiol (1985); 2011 Jun; 110(6):1656-63. PubMed ID: 21415170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical and morphological aspects of the calcaneal tendon of mdx mice at 21 days of age.
    Nakagaki WR; Tomiosso TC; Pimentel ER; Camilli JA
    Anat Rec (Hoboken); 2013 Oct; 296(10):1546-51. PubMed ID: 23934706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered nuclear dynamics in MDX myofibers.
    Iyer SR; Shah SB; Valencia AP; Schneider MF; Hernández-Ochoa EO; Stains JP; Blemker SS; Lovering RM
    J Appl Physiol (1985); 2017 Mar; 122(3):470-481. PubMed ID: 27979987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo anisotropic mechanical properties of dystrophic skeletal muscles measured by anisotropic MR elastographic imaging: the mdx mouse model of muscular dystrophy.
    Qin EC; Jugé L; Lambert SA; Paradis V; Sinkus R; Bilston LE
    Radiology; 2014 Dec; 273(3):726-35. PubMed ID: 25105354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive mechanical properties of maturing extensor digitorum longus are not affected by lack of dystrophin.
    Wolff AV; Niday AK; Voelker KA; Call JA; Evans NP; Granata KP; Grange RW
    Muscle Nerve; 2006 Sep; 34(3):304-12. PubMed ID: 16770793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
    Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
    J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Simonetti S; Papadia F; Camerino DC
    Br J Pharmacol; 2001 Mar; 132(5):1047-54. PubMed ID: 11226135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of P2RX7 ablation on the morphological, mechanical and tissue properties of bones in a murine model of duchenne muscular dystrophy.
    Mohamad NS; Sinadinos A; Górecki DC; Zioupos P; Tong J
    J Biomech; 2016 Oct; 49(14):3444-3451. PubMed ID: 27663621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanosensitive channel properties and membrane mechanics in mouse dystrophic myotubes.
    Suchyna TM; Sachs F
    J Physiol; 2007 May; 581(Pt 1):369-87. PubMed ID: 17255168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.